Your healthcare provider will have to inform Cigna that you have performed behavioral modifications (e.g., increasing exercise) and a reduced-calorie diet for at least three months, and have either: A BMI of 30 or higher, or A BMI of 27 or higher, plus a weight-related comorbidity approved by Cigna, such as hypertension, Type 2 diabetes, dyslipidemia (high cholesterol), obstructive sleep apnea, or cardiovascular disease Wegovy is also FDA approved for cardiovascular risk reduction
Risk of Other Health Issues: Insulin resistance has also been associated with an increased risk of certain cancers, sleep apnea, and cognitive decline
Thats still significantly less than the $1,349 list price, but its a different program with different pricing
Prolonged B12 deficiency can cause irreversible neurological damage, including peripheral neuropathy, cognitive decline, balance problems, and mood disturbances